Eli Lilly Diabetes Drug Notches Another Win in Competitive Space
Summary : One of Eli Lilly’s diabetes drugs just scored another win with the U.S. Food and Drug Administration to expand its…
Summary : One of Eli Lilly’s diabetes drugs just scored another win with the U.S. Food and Drug Administration to expand its…
Synopsis : In November 2018, Cipla had announced that InvaGen Pharmaceuticals Inc has entered into definitive agreements to acquire US-based speciality business…
Summary : The company will invest up ₹6 crore for the 33% stake in the target firm Cipla on Wednesday announced that…
Highlights: The US drug major Eli Lilly has filed a patent infringement litigation at the Delhi High Court against several Indian pharmaceutical…
Cipla healthcare has launched Naselin antiviral nasal spray with Povidone Iodine that can offer the first line of defence against the COVID-causing…
Mumbai Eli Lilly and Company (India) Pvt. Ltd. (hereinafter referred as “Lilly”), headquartered in Gurgaon, is a wholly-owned subsidiary of Eli Lilly…